Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An interferon gamma response signature links myocardial aging and immunosenescence. | Cardiovasc Res | 2023 | 37141306 | PubTator, text mining | PubMed |
| Applying causal discovery to single-cell analyses using CausalCell. | Elife | 2023 | 37129360 | PubTator, text mining | PubMed |
| Single-cell sequencing of immune cells after marathon and symptom-limited cardiopulmonary exercise. | iScience | 2023 | 37123249 | PubTator, text mining | PubMed |
| Multiomic landscape of immune pathogenesis in Kimura's disease. | iScience | 2023 | 37123228 | PubTator, text mining | PubMed |
| Screening prognostic markers for hepatocellular carcinoma based on pyroptosis-related lncRNA pairs. | BMC Bioinformatics | 2023 | 37120506 | PubTator, text mining | PubMed |
| Insufficient epitope-specific T cell clones are responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in older adults. | Nat Aging | 2023 | 37117789 | PubTator, text mining | PubMed |
| Cuproptosis-related molecular subtypes direct T cell exhaustion phenotypes and therapeutic strategies for patients with lung adenocarcinoma. | Front Pharmacol | 2023 | 37113755 | PubTator, text mining | PubMed |
| PTGES Expression Is Associated with Metabolic and Immune Reprogramming in Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2023 | 37108468 | PubTator, text mining | PubMed |
| The Search for the Pathogenic T Cells in the Joint of Rheumatoid Arthritis: Which T-Cell Subset Drives Autoimmune Inflammation? | Int J Mol Sci | 2023 | 37108093 | PubTator, text mining | PubMed |
| Repurposing of RAS-Pathway Mediated Drugs for Intestinal Inflammation Related Diseases for Treating SARS-CoV-2 Infection. | Curr Microbiol | 2023 | 37106165 | PubTator, text mining | PubMed |
| Programmed cell death-1 receptor-mediated regulation of Tbet+NK1.1- innate lymphoid cells within the tumor microenvironment. | Proc Natl Acad Sci U S A | 2023 | 37098069 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis profiles the expression features of TMEM173 in BM cells of high-risk B-cell acute lymphoblastic leukemia. | BMC Cancer | 2023 | 37095455 | PubTator, text mining | PubMed |
| Human CCR6+ Th Cells Show Both an Extended Stable Gradient of Th17 Activity and Imprinted Plasticity. | J Immunol | 2023 | 37093875 | PubTator, text mining | PubMed |
| Transforming RNA-Seq gene expression to track cancer progression in the multi-stage early to advanced-stage cancer development. | PLoS One | 2023 | 37093793 | PubTator, text mining | PubMed |
| Biomaterial-assisted tumor therapy: A brief review of hydroxyapatite nanoparticles and its composites used in bone tumors therapy. | Front Bioeng Biotechnol | 2023 | 37091350 | PubTator, text mining | PubMed |
| A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes. | Front Immunol | 2023 | 37090691 | PubTator, text mining | PubMed |
| Modeling cross-talk of RNA modification enzymes reveals tumor microenvironment-associated clinical significance and immunotherapy prediction in hepatobiliary malignancy. | MedComm (2020) | 2023 | 37090117 | PubTator, text mining | PubMed |
| Case report: Fulminant type 1 diabetes following paucisymptomatic SARS-CoV-2 infection during late pregnancy. | Front Endocrinol (Lausanne) | 2023 | 37082120 | PubTator, text mining | PubMed |
| T cell aging and Alzheimer's disease. | Front Immunol | 2023 | 37081887 | PubTator, text mining | PubMed |
| The Chromatin Landscape of Pathogenic Transcriptional Cell States in Rheumatoid Arthritis. | bioRxiv | 2023 | 37066336 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=36